Leveraging its position as a global law firm, the erudite team at Herbert Smith Freehills Kramer LLP is noted for having excellent capabilities managing both contentious and non-contentious matters for a roster of clients which includes large multi-billion pharmaceutical and medical companies. Noted for handling parallel proceedings across many jurisdictions, the team is led by Alexandra Neri and Frédéric Chevallier, who has gained a wealth of experience in life sciences and technology patent litigation, including the related regulatory aspects of pharmaceuticals. Recent work to highlight includes representing a major French multinational pharmaceutical and healthcare company in complex patent infringement litigation before the UPC.
Legal 500 Editorial commentary
- Profile
- Social
Testimonials
Collated independently by Legal 500 research team.
- ‘Creativity - business oriented - flexibility - speed.'
- 'Frédéric Chevallier is recommended.'
Key clients
- Sanofi
- Roche
- Foundation Medicine
- Millennium Pharmaceuticals, Inc.
- Janssen Pharmaceuticals
Work highlights
- Advising Sanofi on one of its innovative products, Jevtana, for the treatment of prostate cancer (cabazitaxel) in four infringement actions started before the Unified Patent Court.
- Advising Sanofi on one of its fastest growing products, Jevtan®, for the treatment of prostate cancer (cabazitaxel).
- Representing Millennium Pharmaceuticals Inc., Takeda Pharmaceuticals and its exclusive licensee Janssen, in the enforcement strategy of their patents protecting their blockbuster bortezomib comprising product against generic entry.
Lawyers
Practice head
Alexandra Neri; Frédéric Chevallier